| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 49 |
| 1 | ASPIRIN 325 MG | 48 |
| 2 | ASPIRIN 81 MG | 48 |
| 3 | FUROSEMIDE | 39 |
| 4 | OMEPRAZOLE MAGNESIUM | 35 |
| 5 | OMEPRAZOLE | 32 |
| 6 | ADALIMUMAB | 30 |
| 7 | DABIGATRAN ETEXILATE | 30 |
| 8 | CLOZAPINE | 29 |
| 9 | DABIGATRAN ETEXILATE MESYLATE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTICOAGULANT SODIUM CITRATE SOLUTION | 1 | 0.0476 |
| 1 | CARBON DIOXIDE | 2 | 0.0174 |
| 2 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 3 | PHENTOLAMINE MESYLATE | 1 | 0.0062 |
| 4 | MEPROBAMATE | 7 | 0.0054 |
| 5 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 6 | ISOFLURANE | 8 | 0.0041 |
| 7 | EPTIFIBATIDE | 3 | 0.0039 |
| 8 | COAGULATION FACTOR VIIA (RECOMBINANT) | 10 | 0.0037 |
| 9 | ANGIOTENSIN II | 1 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 101 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 81 |
| 2 | Benzodiazepine [EPC] | 63 |
| 3 | Proton Pump Inhibitor [EPC] | 55 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 52 |
| 5 | Atypical Antipsychotic [EPC] | 51 |
| 6 | Loop Diuretic [EPC] | 42 |
| 7 | Factor Xa Inhibitor [EPC] | 38 |
| 8 | Platinum-based Drug [EPC] | 36 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 14 | 0.0011 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 7 | 0.0009 |
| 4 | Antihypoglycemic Agent [EPC] | 3 | 0.0007 |
| 5 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 6 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 7 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 9 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |